Early results from a randomized trial for lung cancer using autoantibody biomarkers were announced at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer, held Sept. 6–9 in Denver.
Read More »Early results from a randomized trial for lung cancer using autoantibody biomarkers were announced at the International Association for the Study of Lung Cancer’s 16th World Conference on Lung Cancer, held Sept. 6–9 in Denver.
Read More »